Sector
HealthcareOpen
₹163.05Prev. Close
₹170.9Turnover(Lac.)
₹9.15Day's High
₹166Day's Low
₹162.452 Week's High
₹181.8552 Week's Low
₹51.78Book Value
₹33.88Face Value
₹10Mkt Cap (₹ Cr.)
114.23P/E
74.89EPS
2.19Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 6.97 | 6.97 | 6.97 | 6.97 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 15.25 | 14.14 | 10.94 | 10.78 |
Net Worth | 22.22 | 21.11 | 17.91 | 17.75 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 25.68 | 28.15 | 31.19 | 28.76 |
yoy growth (%) | -8.77 | -9.73 | 8.46 | 28.94 |
Raw materials | -2.56 | -3.24 | -3.47 | -2.97 |
As % of sales | 9.98 | 11.51 | 11.13 | 10.34 |
Employee costs | -11.5 | -12.83 | -11.39 | -9.45 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -2.8 | -3.28 | 1.93 | 1.3 |
Depreciation | -4.6 | -4.56 | -3.16 | -2.86 |
Tax paid | 0.2 | 1.82 | -0.58 | -0.41 |
Working capital | -1.74 | 0.02 | 0.7 | -1.14 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -8.77 | -9.73 | 8.46 | 28.94 |
Op profit growth | 45.14 | -55.13 | 32.48 | -5.94 |
EBIT growth | -100.72 | -139.53 | 26.84 | 17.39 |
Net profit growth | -32.87 | -388.39 | 50.92 | 23.65 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,161.9 | 149.54 | 1,12,953.74 | 177.39 | 0.13 | 658.7 | 85.26 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,008.55 | 77.73 | 1,00,772.2 | 333.4 | 0.4 | 2,075.3 | 607.44 |
Fortis Healthcare Ltd FORTIS | 748.45 | 440.26 | 56,504.84 | -42.23 | 0.13 | 388.47 | 120.19 |
Narayana Hrudayalaya Ltd NH | 1,871.4 | 88.69 | 38,244.08 | 159.98 | 0.24 | 919.03 | 106.95 |
Global Health Ltd MEDANTA | 1,163 | 62.66 | 31,236.71 | 93.41 | 0.04 | 802.87 | 130.22 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & MD & CEO
Sunil Choksi
Whole-time Director
Stela Choksi
Whole Time Director & CFO
Vyangesh Choksi
Whole-time Director
Himika Choksi
Independent Director
Raghmendra Singh
Company Sec. & Compli. Officer
Prakhar Dubey
Independent Director
Meenaxi Patidar
Independent Director
Prachi Mantri
Independent Director
Abha Shastri
Survey no 9/1 Gram Kumerdi,
Near to Tulshiyana Indl Park,
Madhya Pradesh - 452010
Tel: -
Website: http://www.choksilab.com
Email: compliance_officer@choksilab.com, indore@choksilab
C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078
Tel: 91-022-25963838
Website: www.linkintime.co.in
Email: rnt.helpdesk@linkintime.co.in/mumbai@linkintime.co.in
Summary
Choksi Laboratories Limited, incorporated on 29 January, 1993 provides contract testing and analytical services. CLL is a group of research laboratories and consulting offices, offering analysis, cali...
Read More
Reports by Choksi Laboratories Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.